Home Data Calendar Blog

OPK

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Common Stock Value 7.817.816.906.906.906.906.716.716.716.706.706.706.166.166.165.875.605.605.605.605.605.605.605.595.585.485.485.465.464.654.594.334.334.274.154.154.093.393.393.062.98
Weighted Average Number Of Diluted Shares Outstanding 750.40712.55660.30NA651.84647.00640.85NA640.70640.58NANANANANANANA559.54NANANA564.16NANA552.23557.04NANA514.32462.25NANA427.58NANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 750.40712.55660.30NA651.84647.00640.85NA640.70640.58NANANANANANANA559.54NANANA559.35NANA552.23547.56NANA500.56462.25NANA427.58NANANANANANANANA
Earnings Per Share Basic -0.11-0.14-0.08-0.110.04-0.030.050.050.040.05-0.09NANANANANANA-0.01NA-0.38-0.08-0.03-0.06-0.02-0.030.03-0.020.000.26-0.09-0.26-0.12-0.11-0.06-0.11NANANANANANA
Earnings Per Share Diluted -0.11-0.14-0.08-0.110.04-0.030.050.050.040.05-0.09NANANANANANA-0.01NA-0.38-0.08-0.04-0.06-0.04-0.030.02-0.020.000.25-0.09-0.26-0.12-0.11-0.08-0.11NANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Revenue From Contract With Customer Excluding Assessed Tax 179.74309.89329.22401.33385.81442.41545.16494.68428.06301.21211.47224.34228.77226.37222.45221.85249.81263.69211.31160.98246.04292.60228.54339.94259.02266.01252.52221.81103.921.912.072.062.482.151.972.612.773.193.091.420.10
Gain Loss On Investments -0.04-0.27-0.05-0.47-0.05-0.07-0.04-0.05-0.11-0.19-0.13-0.48-0.29-0.27-1.85-2.96-1.87-7.21-2.46-2.70-4.01-5.63-2.13-2.50-0.81-1.99-2.35-1.04-3.50-0.80-1.76-1.10-0.06-0.37-2.06NANA-2.37-3.89-0.60-0.47
Operating Expenses 267.56320.63401.64464.42347.99436.84506.73445.32406.12274.03252.23336.81267.78273.63297.77311.87283.28268.79297.52347.32321.79340.66337.80325.89321.66328.83318.56284.13151.2667.8487.0057.9967.9758.4352.5556.5639.6541.8026.3917.1213.68
Research And Development Expense 18.7917.2518.3121.0118.3118.2219.3217.4518.4917.6121.7623.0430.0228.2936.5333.3330.1629.2132.8934.2432.3332.5926.0227.6124.4231.3527.8225.4818.9429.5725.5025.8320.5216.2320.9923.3511.099.569.916.583.62
Selling General And Administrative Expense 79.67101.46117.54138.21105.12113.24112.29101.8299.9077.7276.1379.1380.5488.4795.1695.1084.0787.6591.52124.64131.34128.34136.69120.53124.84117.51128.00102.9555.2520.9417.4515.2414.0114.8713.8115.4513.5713.8812.4210.377.32
Operating Income Loss -87.82-10.74-72.42-63.0837.835.5738.4449.3621.9427.18-40.76-112.46-39.01-47.26-75.32-90.01-33.46-5.11-42.61-153.62-58.29-26.44-41.71-50.40-23.6228.27-27.52-7.93-8.22-25.41-56.91-32.45-48.20-34.88-30.28-35.87-19.01-17.98-6.77-1.06-9.37
Interest Paid Net 3.460.133.420.133.500.194.690.255.080.575.010.795.674.900.510.450.85NANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 3.404.307.60NA3.803.502.60NA2.701.602.50NA3.403.104.50NA5.105.605.90NA6.506.109.70NANANANANANANANANANANANANANA1.805.201.801.10
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -126.38-86.31-76.65-65.8131.47-11.3731.6845.9420.6539.92-57.83-108.44-59.94-58.45-78.12-101.41-37.343.03-41.55-150.04-66.83-22.86-35.81-42.64-34.1533.39-30.14-23.8238.77-42.19-110.77-53.35-49.66-25.61-42.42-14.42-57.91-1.06-30.83-10.08-9.49
Income Tax Expense Benefit -40.3315.07-21.277.502.684.750.5613.60-3.186.031.173.421.771.080.78-28.29-11.562.02-0.8961.16-24.41-10.96-6.94-31.49-19.9915.87-20.51-26.46-92.980.255.51-0.980.290.100.61-0.591.290.930.04-9.71-0.13
Income Taxes Paid Net -0.183.581.060.461.822.221.47-1.050.36-1.010.80-0.440.971.111.02-5.29-1.372.962.29-0.481.583.470.85-35.170.875.671.503.500.630.530.230.39-0.230.420.381.000.070.36-0.120.060.32
Net Income Loss -86.09-101.65-55.43-73.7728.74-16.1931.0832.3023.7233.70-59.13-112.35-62.01-59.81-80.76-76.07-27.66-6.20-43.11NANANANANANANANANANANANA-52.97-48.67-25.48-44.55-16.80-60.00-3.39-34.22-0.55-9.65
Comprehensive Income Net Of Tax -94.95-119.41-56.35-84.3518.75-12.8222.0145.5232.0238.14-67.25NANANANANANANANANANANA-28.94NA-7.839.21-6.550.06126.13-44.14-122.22-56.67-57.67-26.57-46.57-16.62-59.59-8.66-33.90-2.76-7.92

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Assets 2224.782369.602306.862399.722417.642421.652519.572473.062371.292323.732232.542309.272369.522456.232575.302451.072480.992530.952578.892584.562721.992768.692760.072766.622800.032774.022793.212799.613015.851525.491512.251267.661295.241327.081355.691391.521382.98641.08653.93289.83250.02
Liabilities 595.72650.80691.97714.59652.07679.07823.06801.51747.52735.39683.92694.51727.59747.30812.56659.78692.35720.45755.63699.18632.95661.87653.10674.81694.63758.38795.33819.821046.48698.50699.68431.92407.90414.26524.44518.54515.06328.60334.1686.5579.37
Liabilities And Stockholders Equity 2224.782369.602306.862399.722417.642421.652519.572473.062371.292323.732232.542309.272369.522456.232575.302451.072480.992530.952578.892584.562721.992768.692760.072766.622800.032774.022793.212799.613015.851525.491512.251267.661295.241327.081355.691391.521382.98641.08653.93289.83250.02

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Assets Current 413.97494.75754.07823.01557.51547.03599.05523.18428.11360.05274.46324.05292.84344.23435.24317.73289.82321.56349.35343.46430.56472.52459.93483.60502.07505.57453.53454.06517.42278.34394.02142.87163.15183.01205.27242.73241.28230.12237.6878.6687.98
Cash And Cash Equivalents At Carrying Value 180.84210.46102.28134.71148.6065.7689.5072.2136.2921.6134.5385.4564.67111.11207.2596.4743.7280.3899.9491.50100.36130.53131.05168.73144.65156.01174.97193.60212.14221.22348.1996.91118.26134.01156.40185.80155.83119.06181.6027.3623.43
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 180.84210.46102.28134.71148.6065.7689.5072.2136.2921.6134.5385.4564.67111.11207.2596.4743.7280.3899.9491.50NANANA168.73NANANANANANANANANANANANANANANANANA
Accounts Receivable Net Current 123.19158.43212.75259.64255.19265.86320.46286.31241.54214.35132.48134.62140.76148.29144.38143.91157.37152.78158.64165.52233.92251.75238.89220.28223.83213.37204.48193.88189.7226.9819.0619.9721.2123.1119.6619.7721.3722.2321.1721.1619.14
Inventory Net 71.4383.3199.4186.50112.86134.72159.10132.34111.8772.9758.7053.4350.1148.2944.6142.3043.3846.7549.8149.3346.9548.2947.4947.2343.1942.0540.5839.6840.6920.5218.3216.6016.6618.3318.8618.0819.5219.7823.0222.2621.49
Inventory Finished Goods 37.1942.3246.5944.1140.6438.8739.2936.8330.2724.2623.7325.1422.1421.4818.8915.2614.9316.7822.1421.0122.8821.8219.7316.1414.0313.9414.7913.4013.8513.8314.3512.1211.3612.4612.8813.3714.7815.1719.1817.9617.75
Other Assets Current 6.346.364.836.2011.0015.885.065.317.5419.0615.7915.843.333.234.513.854.244.764.373.843.883.293.857.510.870.780.310.902.363.393.384.212.592.615.665.654.30NANA4.75NA
Prepaid Expense And Other Assets Current 38.5242.5623.2727.1740.8647.6329.9832.3138.4051.1248.7550.5437.3036.5338.9935.0545.3541.6540.9537.1149.3241.9542.4947.3690.4178.5133.5126.9074.859.628.459.397.027.5510.3519.0819.5519.0211.897.875.00
Equity Securities Fv Ni 1.231.513.064.236.557.478.8414.1412.7224.788.9918.879.1320.8627.7226.3122.1822.35NANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Amortization Of Intangible Assets 21.4122.7922.0212.5212.6112.5712.5812.6413.8814.9414.9415.3916.4116.4216.5616.5316.9017.2317.3030.7818.0217.9517.9017.0718.1215.7813.4413.978.113.242.672.622.732.832.742.942.792.692.712.022.18
Long Term Investments 77.80108.699.4710.7311.758.9510.4115.7314.3226.2610.6720.7511.7024.7732.3031.2342.7445.5041.2940.6432.2034.4937.2841.1438.7834.2535.2134.7234.7021.4322.3822.4526.8533.4335.7030.6524.6926.6928.5515.6415.00
Goodwill 573.50578.85519.05520.60674.57677.36676.16680.60675.79671.60669.58671.94695.80699.84698.52700.19713.63714.23719.89717.10715.57712.08705.99704.60700.53691.06746.96743.35761.23289.61223.22224.29224.77226.00226.06226.37222.3482.0982.7180.4549.74
Indefinite Lived Intangible Assets Excluding Goodwill 1000.001057.40890.50911.901000.001000.001000.001100.001100.001100.001100.001100.00635.00635.57635.56635.57646.34645.71646.39647.35648.38645.96645.06644.71646.97606.03793.63792.27812.72812.45793.00793.15793.21793.33793.34793.34793.31NANA11.55NA
Finite Lived Intangible Assets Net 835.14862.41890.50321.68433.86445.51456.31475.00486.42499.12513.51528.96564.31581.31597.32614.45631.43648.54667.64683.84714.55731.13746.65763.98781.89804.45625.40638.15660.2994.2559.4362.6565.5569.0671.9274.5377.3379.7882.3595.7882.59
Other Assets Noncurrent 9.648.909.109.538.749.609.7410.065.867.497.036.895.533.773.137.229.655.255.635.6238.3039.1638.895.764.304.384.525.27102.686.015.075.844.674.916.526.867.002.782.862.781.87
Equity Securities Fv Ni 1.231.513.064.236.557.478.8414.1412.7224.788.9918.879.1320.8627.7226.3122.1822.35NANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Liabilities Current 267.27215.47309.17330.01283.04303.98403.93375.48335.89279.54245.09249.12270.14283.37396.06288.32317.83306.86318.08301.33258.95283.05264.95263.30254.51281.24267.23251.90357.59180.48182.8483.1176.8479.4084.5091.8571.3859.4758.2252.3846.44
Accounts Payable Current 49.7556.1194.2482.0494.3988.51162.69100.8865.6944.6755.8762.5477.3060.3851.0947.4065.6169.0664.2374.3166.5462.1574.5653.3658.5461.0673.4472.5377.9716.0410.478.748.8410.0414.7013.4113.6311.6511.2910.207.24
Other Accrued Liabilities Current 43.1650.5647.1569.3055.3169.2069.4878.4373.2556.8868.1058.8584.4481.9080.8462.2977.0165.4275.9379.3647.5750.1938.7058.1837.6236.3123.2223.7519.8615.2310.3914.6512.3214.2112.7115.885.89NANA6.18NA
Accrued Liabilities Current 112.02128.25157.32193.49163.93187.17213.12240.87248.42210.11164.94164.93172.73198.38217.53203.51214.91200.99217.13215.10176.30206.40178.87197.96186.08209.85182.34167.90201.11149.84158.7660.9155.5554.9658.7765.8743.2731.0526.6724.6621.79
Contract With Customer Liability Current 0.260.260.260.263.008.4015.0315.7814.1016.5710.4619.2030.9550.3965.2963.5061.7361.8561.3861.39NANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Liabilities Noncurrent 328.44435.33382.80384.58369.04375.08419.13426.03411.63455.85438.84445.39457.45463.92416.51371.46374.52413.59437.55397.84374.01378.81388.15411.51440.12477.14528.10567.92688.89518.02516.84348.81331.06334.86439.94426.69443.68269.13275.9334.17NA
Long Term Debt 244.98232.45230.26205.27202.59205.68246.52251.21NANANA270.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANA3.95
Deferred Income Tax Liabilities Net 135.07176.74125.03148.49134.25136.42135.24137.21119.18118.98118.60118.72113.48113.33116.01115.19134.11148.25148.73148.73118.80142.21159.29165.33NANANA226.04NANANANANANANANANANANANANA
Other Liabilities Noncurrent 22.5516.2415.6615.0620.9924.8726.7137.0745.0391.6577.7687.80111.96127.7578.17198.97183.81209.44233.62219.95226.62201.84189.58202.48204.09224.32275.81292.47236.48408.82410.17217.36216.17218.49215.14214.78234.7680.6079.5134.1732.93
Operating Lease Liability Noncurrent 29.0030.8831.6033.1028.2630.6132.3929.7628.2328.7628.6727.6623.3216.6718.62NANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1629.071718.801614.881685.131765.571742.591696.511671.551623.771588.341548.621614.761641.931708.931762.741791.291788.641810.501823.261885.382089.042106.832106.972091.812105.392015.641997.871979.791969.37826.99812.57835.74887.34912.83831.25872.98867.93312.48319.78178.89NA
Common Stock Value 7.817.816.906.906.906.906.716.716.716.706.706.706.166.166.165.875.605.605.605.605.605.605.605.595.585.485.485.465.464.654.594.334.334.274.154.154.093.393.393.062.98
Additional Paid In Capital 3418.763413.563191.143222.493218.583214.353155.653152.693150.443147.033145.443142.993065.063061.633058.513004.422907.022901.092895.192889.262883.032863.032856.642845.102834.302736.822728.262705.392696.421687.391628.821529.101523.551490.071384.691379.381357.23742.10739.78565.20529.96
Retained Earnings Accumulated Deficit -1737.69-1651.60-1549.95-1511.98-1438.20-1466.94-1450.76-1481.83-1514.13-1537.85-1571.55-1511.08-1398.73-1336.72-1276.91-1197.08-1109.05-1081.40-1075.20-1007.16-792.38-745.93-728.41-729.95-716.29-701.32-716.85-704.87-706.47-834.72-791.96-674.84-621.87-573.20-547.73-503.18-486.38-426.38-422.99-388.77-388.22
Accumulated Other Comprehensive Income Loss Net Of Tax -58.03-49.17-31.41-30.50-19.92-9.93-13.29-4.22-17.45-25.75-30.19-22.07-28.77-20.35-23.23-20.13-13.14-13.00-0.54-0.53-5.42-14.07-24.95-27.01-16.28-23.43-17.11-22.54-20.99-18.88-17.50-12.39-8.700.301.403.423.242.838.097.369.00
Treasury Stock Value NANA1.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.791.911.911.911.911.913.653.653.654.054.054.054.057.307.367.467.467.467.467.46
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3.394.317.623.703.823.462.652.172.741.592.452.413.433.124.465.175.085.585.94NANANANANANANANANANANANANANANANA3.570.411.805.21NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Net Cash Provided By Used In Operating Activities -32.24-11.48-19.86-5.6433.40-15.4526.0434.2663.01-14.42-43.37-46.04-23.87-53.63-48.99-34.66-21.88-17.08-35.522.11-37.61-22.66-33.9230.31-31.9042.84-9.21-9.35-31.36-34.05238.79-24.76-21.08-15.49-29.05-26.05-11.47-5.92-14.74-5.73-1.93
Net Cash Provided By Used In Investing Activities -4.68108.50-4.90-8.6854.58-8.84-1.11-6.745.50-11.46-5.62-3.76-2.19-3.19-4.13-2.88-11.57-6.52-5.15-13.95-16.30-9.97-6.44-6.4819.49-23.65-10.06-7.947.17-98.09-0.36-0.80-1.54-3.07-0.2638.8745.29-53.20-0.658.43-10.80
Net Cash Provided By Used In Financing Activities 8.4412.27-7.890.83-4.260.27-7.198.11-54.4612.89-1.6170.64-20.00-39.28163.8890.70-3.004.0249.194.2322.9031.742.171.780.96-37.990.05-0.1714.694.6713.814.137.13-3.90-0.1017.042.81-3.32169.641.05-1.77

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Net Cash Provided By Used In Operating Activities -32.24-11.48-19.86-5.6433.40-15.4526.0434.2663.01-14.42-43.37-46.04-23.87-53.63-48.99-34.66-21.88-17.08-35.522.11-37.61-22.66-33.9230.31-31.9042.84-9.21-9.35-31.36-34.05238.79-24.76-21.08-15.49-29.05-26.05-11.47-5.92-14.74-5.73-1.93
Net Income Loss -86.09-101.65-55.43-73.7728.74-16.1931.0832.3023.7233.70-59.13-112.35-62.01-59.81-80.76-76.07-27.66-6.20-43.11NANANANANANANANANANANANA-52.97-48.67-25.48-44.55-16.80-60.00-3.39-34.22-0.55-9.65
Depreciation Depletion And Amortization 28.0028.0027.8119.1918.9620.5719.9920.0721.0422.2722.0522.5323.8023.6623.8223.9023.9224.7624.7625.4225.3925.5525.7323.9625.8324.5822.2022.1812.404.153.523.663.684.033.564.573.773.453.432.712.66
Increase Decrease In Accounts Receivable -34.19-51.44-44.4222.70-7.58-55.5935.2443.1825.7280.780.76-4.12-7.663.960.44-12.704.74-5.68-6.76-71.61-17.2713.0917.77-3.3410.598.469.9215.389.204.710.10-0.22-0.183.760.56-1.48-0.931.090.56-0.95-2.50
Increase Decrease In Inventories -8.45-12.339.46-16.43-18.07-24.0927.9117.0838.6613.078.832.593.323.752.48-0.53-3.16-0.69-0.205.27-2.170.390.053.880.961.610.15-0.533.150.652.610.65-0.31-0.261.68-0.940.26-2.651.441.361.12
Increase Decrease In Accounts Payable -5.49-35.6516.14-6.106.91-73.8862.2333.9020.01-11.89-4.87-14.9617.719.173.71-16.75-1.242.11-10.218.162.57-10.1019.54-3.68-2.94-12.86-0.3517.38-42.604.992.11-0.00-0.54-4.791.48-0.471.970.44-0.101.580.47
Deferred Income Tax Expense Benefit -39.9413.41-22.367.78-0.103.51-1.0313.670.950.410.612.261.900.52-0.35-20.61-12.520.68-2.7162.46-23.33-13.80-9.24-30.50-21.9813.24-22.24-26.82-96.710.000.00-1.020.000.000.000.800.41-0.700.10-9.960.00
Share Based Compensation 3.394.317.623.703.823.462.652.172.741.592.452.413.433.124.465.175.085.585.946.016.496.119.697.768.838.8017.318.313.676.717.384.693.103.403.583.570.401.805.211.851.10
Amortization Of Financing Costs 0.290.290.280.180.180.200.220.220.210.210.200.490.20-0.100.410.030.060.060.040.060.060.060.060.060.100.040.040.040.280.140.750.100.101.630.180.180.650.200.140.000.00

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Net Cash Provided By Used In Investing Activities -4.68108.50-4.90-8.6854.58-8.84-1.11-6.745.50-11.46-5.62-3.76-2.19-3.19-4.13-2.88-11.57-6.52-5.15-13.95-16.30-9.97-6.44-6.4819.49-23.65-10.06-7.947.17-98.09-0.36-0.80-1.54-3.07-0.2638.8745.29-53.20-0.658.43-10.80
Payments To Acquire Productive Assets 7.615.385.256.737.238.959.246.809.7411.525.633.882.433.502.933.0412.036.825.9714.4615.267.279.541.534.153.059.816.422.981.080.360.801.471.610.860.970.941.300.760.410.66

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Net Cash Provided By Used In Financing Activities 8.4412.27-7.890.83-4.260.27-7.198.11-54.4612.89-1.6170.64-20.00-39.28163.8890.70-3.004.0249.194.2322.9031.742.171.780.96-37.990.05-0.1714.694.6713.814.137.13-3.90-0.1017.042.81-3.32169.641.05-1.77

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30
Revenue From Contract With Customer Excluding Assessed Tax 179.74309.89329.22401.33385.81442.41545.16494.68428.06301.21211.47224.34228.77226.37222.45221.85249.81263.69211.31160.98246.04292.60228.54339.94259.02266.01252.52221.81103.921.912.072.062.482.151.972.612.773.193.091.420.10
Operating, Transfer Of Intellectual Property And Other, Pharmaceutical 4.5087.205.963.268.779.554.275.926.8214.699.5514.3621.4719.2318.2613.4421.6119.1115.757.8422.3729.72NANANANANANANANANANANANANANANANANANANA
Operating, Product, Pharmaceutical 32.3935.8936.6635.2836.8835.6633.9530.8228.7029.3631.0732.0426.1628.6825.3025.3425.3928.5227.8533.7722.8028.97NANANANANANANANANANANANANANANANANANANA
Operating, Service, Diagnostics 142.86186.80286.60362.79340.16397.20506.95457.93382.50250.97170.84177.95181.14178.46178.89183.07202.81216.06211.31119.38200.88233.91NANANANANANANANANANANANANANANANANANANA
Pfizer, Transfer Of Intellectual Property And Other, Product 2.202.302.202.702.502.802.802.903.1013.908.7011.7019.5018.2017.40NA18.9016.30NANANANANANANANANANANANANANANANANANANANANANANA
Vifor Fresenius Medical Care Pharma Ltd, Transfer Of Intellectual Property And Other, Product 0.000.003.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Client Payers 61.7080.93159.04185.93168.64225.94262.91249.57207.89141.0939.1339.6643.7538.1038.4234.1437.7745.8337.5322.3734.7242.9633.94NANANANANANANANANANANANANANANANANANA
Government Payers 20.1525.6627.5942.7748.2057.6173.6625.9721.5415.8926.9329.4228.2128.6329.5162.2767.9172.4667.1438.0067.3580.0477.05NANANANANANANANANANANANANANANANANANA
Health Insurers 58.0876.4495.78128.47117.89109.08164.83163.88136.5384.0899.08103.87104.02106.28105.8882.0392.0692.03100.9555.5692.98104.37112.70NANANANANANANANANANANANANANANANANANA
Patients 2.933.774.195.635.434.575.5618.5216.549.915.704.995.165.455.084.635.075.745.703.445.836.554.86NANANANANANANANANANANANANANANANANANA
Rayaldee 14.5015.3813.4817.2015.3316.1215.6420.6222.0122.8822.6826.7219.6614.8512.7312.6410.49NANANANANANANANANANANANANANANANANANANANANANANANA
Transfer Of Intellectual Property And Other 4.5087.205.963.268.779.554.275.9216.8620.889.5514.3621.4719.2318.2613.4421.6119.1115.757.8422.3729.72NANANANANANANANANANANANANANANANANANANA
Product 32.3935.8936.6635.2836.8835.6633.9530.8228.7029.3631.0732.0426.1628.6825.3025.3425.3928.5227.8533.7722.8028.97NANANANANANANANANANANANANANANANANANANA
Service 142.86186.80286.60362.79340.16397.20506.95457.93382.50250.97170.84177.95181.14178.46178.89183.07202.81216.06211.31119.38200.88233.91NANANANANANANANANANANANANANANANANANANA
14.3515.8016.3414.5016.4918.6614.1511.0911.0611.1510.858.298.449.057.878.628.9311.9411.7310.7511.5111.9010.128.859.949.606.986.967.788.706.456.407.627.857.297.437.998.487.746.846.78
4.565.707.115.615.725.445.924.933.714.144.165.284.174.884.423.934.144.595.534.544.125.124.503.563.914.324.024.323.454.923.945.094.415.676.155.304.035.154.324.132.00
6.6889.188.468.155.4512.097.136.188.9916.8511.9015.4922.9722.1720.5315.6324.4120.7817.2814.2125.8922.5220.72-0.0220.5971.7922.1425.1822.3119.3812.100.000.000.000.00NANANANANANA
0.251.851.560.020.310.722.510.241.121.181.71-0.051.943.773.121.052.282.533.610.141.947.654.222.463.704.424.743.804.155.944.216.083.716.314.553.593.104.002.572.991.52
3.894.053.752.393.163.042.421.882.281.871.842.801.642.061.531.491.381.301.421.531.480.720.860.680.680.930.710.830.990.970.890.901.531.551.831.141.450.990.891.281.20
US 149.84193.10291.81370.61354.59402.29512.87470.23400.78265.89180.87192.41189.49184.31184.89191.02208.65222.53215.31129.78201.06244.65255.64155.79259.22266.04252.44235.10104.362.522.497.062.482.152.453.244.085.2015.851.020.30
Other Countries 0.170.200.190.070.110.170.160.130.120.130.140.120.130.130.090.110.030.010.020.020.040.030.030.010.000.000.00NANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Equity Securities Fv Ni
Current Assets
Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Operating Lease Liability
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Finished Goods
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept


COGS Ratio
us-gaap:ProductOrService
(None,)
C O G S  Ratious-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'opk:Pharmaceutical')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'opk:TransferOfIntellectualPropertyAndOther', 'us-gaap:Product')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:CostOfGoodsAndServicesSold
us-gaap:ProductOrService
(None,)
Cost Of Goods And Services Soldus-gaap: Product Or Service
us-gaap:OperatingIncomeLoss
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Operating Income Lossus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:Assets
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Assetsus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:Goodwill
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Goodwillus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:Goodwill
us-gaap:BusinessAcquisition, us-gaap:StatementBusinessSegments
(None, 'opk:Pharmaceutical')
Goodwillus-gaap: Business Acquisition, us-gaap: Statement Business Segments
us-gaap:LongTermDebtCurrent
us-gaap:LongtermDebtType
(None,)
Long Term Debt Currentus-gaap: Longterm Debt Type
us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
(None, 'us-gaap:ConvertibleDebt')
Long Term Debtus-gaap: Debt Instrument, us-gaap: Longterm Debt Type
us-gaap:LongTermDebt
us-gaap:LongtermDebtType
(None,)
Long Term Debtus-gaap: Longterm Debt Type
us-gaap:LongTermDebt
us-gaap:BalanceSheetLocation
(None,)
Long Term Debtus-gaap: Balance Sheet Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:DepreciationDepletionAndAmortization
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None)
Depreciation Depletion And Amortizationus-gaap: Consolidation Items, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems, us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
('us-gaap:Operating', None, 'opk:Pharmaceutical')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Consolidation Items, us-gaap: Product Or Service, us-gaap: Statement Business Segments
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'opk:TransferOfIntellectualPropertyAndOther', 'us-gaap:Product')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical